China’s Regulatory Tightening: Our View on Goals and Scope (Franklin Templeton)

China’s government recently enacted new regulations on a number of industries, which has caused some investor concern. Franklin Templeton’s Emerging Markets Equity team follows up some of its initial commentary on the matter here, noting policies do not have a uniform effect on companies. READ MORE

Similar Posts:

• Heightened Regulatory Scrutiny in China: What Investors Need to Know (Franklin Templeton)
• China: Navigating the Regulatory Landscape (UBS AM)
• Evergrande Crisis and Contagion Risks (Franklin Templeton)
• Experts: Tread Carefully With Emerging Market Investments (FE Trustnet)
• Templeton’s Chow: “No Reason the Goat and the Bull Cannot be Friends” (Mobius Blog)
• Health Care: The Next Wave of Innovation in China (Franklin Templeton)
• EXS Capital’s Solberg: China’s Property and Steel Sectors Look Interesting Now (CMN)
• Chinese Manufacturers Get Around US Tariffs With Some Help From Mexico (Bloomberg)
• Stop Worrying About Chinese Debt? (The Asset)
• Pick Stocks, Not Countries, in Emerging Markets (FE Trustnet)
• Fitch Cuts Macau Gaming Revenue Forecast to 4% on VIP Weakness (Fitch)
• Five Misconceptions About China’s Stock Markets (KraneShares)
• What is the SEC Targeting Alibaba (BABA) About? (China Accounting Blog)
• Surviving the Pharma Drug Price Wars in Emerging Markets (PharmExec.com)
• Aberdeen’s Star Manager Says an Emerging Markets Turnaround is Underway (FTAdviser)